Time to load the boat..Fidelitiy owns 700 shares..
FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b) edit: filed feb.14...
Pursuant to the instructions in Item 7 of Schedule
13G, Fidelity Management & Research Company
("Fidelity"), 82 Devonshire Street, Boston, Massachusetts
02109, a wholly-owned subsidiary of FMR Corp. and an
investment adviser registered under Section 203 of the
Investment Advisers Act of 1940, is the beneficial owner of
700 shares or 0.003% of the Common Stock outstanding of
Introgen Therapeutics Incorporated ("the Company") as a
result of acting as investment adviser to various investment
companies registered under Section 8 of the Investment
Company Act of 1940.
The ownership of one investment company, Fidelity
Funds - European Smaller Company Pool, amounted to
1,503,760 shares or 5.537% of the Common Stock
outstanding. Fidelity Funds - European Smaller Company
Pool has its principal business office at Kansallis House,
Place de l'Etoile, BP 2174, L-1021 Luxembourg.
Edward C. Johnson 3d, FMR Corp., through its
control of Fidelity, and the funds each has sole power to
dispose of the 700 shares owned by the Funds. |
